Canada House Wellness Group, a fully integrated medical cannabis company, is pleased to announce that its wholly owned subsidiary, Abba Medix Corp. has fulfilled its first purchase order from Cannabis NB for 3.5-gram dried flower formats of its popular Critical Orange Punch and VetStar Night™ strains.
The Company is pleased to also announce that it has entered into an agreement with a New Brunswick based licensed producer to source locally grown, premium cannabis products to supplement its offerings to Cannabis NB and Abba’s medical patient base. Abba’s Critical Orange Punch and VetStar Night™ are available for immediate sale at Cannabis NB’s 20 retail locations throughout the province as well as through Cannabis NB’s online retail platform at https://www.cannabis-nb.com/.
“As a company that was founded in New Brunswick and continues to maintain clinic headquarters in Oromocto, being able to add New Brunswick to our existing recreational distribution channel is an important milestone for Canada House. We are thrilled to introduce our brand and popular genetics to New Brunswickers, particularly VetStar Night™ which has received rave reviews from our veteran patient base,” commented Canada House’s CEO, Chris Churchill-Smith. “As it is a corporate priority for Canada House to ensure continued supply to our medical patients, at this time VetStar will only be available for recreational purposes in New Brunswick. We look forward to working with Cannabis NB to bring new SKUs, including locally produced cannabis products, to market in the coming weeks.”
About Canada House Wellness Group
Canada House Wellness Group is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; IsoCanMed Inc., a Licensed Producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility employing state-of-the-art vertical, aeroponic production methodologies; Canada House Clinics Inc., with clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis. Please visit www.canadahouse.ca.